Dr Joshua R Lacey, MD | |
2629 N 7th St, Sheboygan, WI 53083-4932 | |
(920) 451-5000 | |
Not Available |
Full Name | Dr Joshua R Lacey |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 13 Years |
Location | 2629 N 7th St, Sheboygan, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407134620 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Aurora Sheboygan Memorial Medical Ctr | Sheboygan, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
Replacing guidelines for managing women with abnormal results on cervical cancer screening tests from 2012, new recommendations from ASCCP emphasize more precise management based on estimates of the patient's risk - enabling more personalized recommendations for diagnosis, treatment, and follow-up.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it has received approval for its real-time PCR-based Epidermal Growth Factor Receptor Assay (the "EGFR PCR Assay") for the use of lung cancer targeted drugs from the State Food and Drug Administration of China (the "SFDA").
The Intellectual Property & Science division of Thomson Reuters unveiled Cortellis for Regulatory Intelligence™ at the DIA 2012 Annual Meeting in Philadelphia today. This new offering is the next generation of Thomson Reuters IDRAC™, the company's best-in-class regulatory intelligence tool that provides pharmaceutical professionals with reliable and accurate global regulatory information to gain competitive advantage and minimize regulatory risks.
"The ruling this week by Australia's high court to uphold its government's right to introduce 'plain packaging' for tobacco products is a landmark event for global health," John Seffrin, CEO of the American Cancer Society, writes in this Health-e opinion piece.
Agenta Biotechnologies, Inc., a private biotechnology company, announced that it has received a $1.1 million grant from the National Institutes of Health and National Institute of Dental and Craniofacial Research (NIH/NIDCR) for the further development of a biologically activated membrane to improve soft tissue healing associated with oral surgery.
› Verified 4 days ago
Entity Name | Aurora Medical Group, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
Replacing guidelines for managing women with abnormal results on cervical cancer screening tests from 2012, new recommendations from ASCCP emphasize more precise management based on estimates of the patient's risk - enabling more personalized recommendations for diagnosis, treatment, and follow-up.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it has received approval for its real-time PCR-based Epidermal Growth Factor Receptor Assay (the "EGFR PCR Assay") for the use of lung cancer targeted drugs from the State Food and Drug Administration of China (the "SFDA").
The Intellectual Property & Science division of Thomson Reuters unveiled Cortellis for Regulatory Intelligence™ at the DIA 2012 Annual Meeting in Philadelphia today. This new offering is the next generation of Thomson Reuters IDRAC™, the company's best-in-class regulatory intelligence tool that provides pharmaceutical professionals with reliable and accurate global regulatory information to gain competitive advantage and minimize regulatory risks.
"The ruling this week by Australia's high court to uphold its government's right to introduce 'plain packaging' for tobacco products is a landmark event for global health," John Seffrin, CEO of the American Cancer Society, writes in this Health-e opinion piece.
Agenta Biotechnologies, Inc., a private biotechnology company, announced that it has received a $1.1 million grant from the National Institutes of Health and National Institute of Dental and Craniofacial Research (NIH/NIDCR) for the further development of a biologically activated membrane to improve soft tissue healing associated with oral surgery.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Joshua R Lacey, MD 2629 N 7th St, Sheboygan, WI 53083-4932 Ph: (920) 451-5000 | Dr Joshua R Lacey, MD 2629 N 7th St, Sheboygan, WI 53083-4932 Ph: (920) 451-5000 |
News Archive
Replacing guidelines for managing women with abnormal results on cervical cancer screening tests from 2012, new recommendations from ASCCP emphasize more precise management based on estimates of the patient's risk - enabling more personalized recommendations for diagnosis, treatment, and follow-up.
China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it has received approval for its real-time PCR-based Epidermal Growth Factor Receptor Assay (the "EGFR PCR Assay") for the use of lung cancer targeted drugs from the State Food and Drug Administration of China (the "SFDA").
The Intellectual Property & Science division of Thomson Reuters unveiled Cortellis for Regulatory Intelligence™ at the DIA 2012 Annual Meeting in Philadelphia today. This new offering is the next generation of Thomson Reuters IDRAC™, the company's best-in-class regulatory intelligence tool that provides pharmaceutical professionals with reliable and accurate global regulatory information to gain competitive advantage and minimize regulatory risks.
"The ruling this week by Australia's high court to uphold its government's right to introduce 'plain packaging' for tobacco products is a landmark event for global health," John Seffrin, CEO of the American Cancer Society, writes in this Health-e opinion piece.
Agenta Biotechnologies, Inc., a private biotechnology company, announced that it has received a $1.1 million grant from the National Institutes of Health and National Institute of Dental and Craniofacial Research (NIH/NIDCR) for the further development of a biologically activated membrane to improve soft tissue healing associated with oral surgery.
› Verified 4 days ago
Dr. Raymond Seth Sohn, D.O Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2124 Kohler Memorial Dr Ste 110, Sheboygan, WI 53081 Phone: 920-204-6758 Fax: 888-720-0495 | |
Dr. Bryan Stuart Wichman, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3100 Superior Ave, Sheboygan, WI 53081 Phone: 920-783-1261 | |
Samuel D. Parks, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3100 Superior Ave, Sheboygan, WI 53081 Phone: 608-263-8114 | |
Dr. Joseph S Bernstein, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3100 Superior Ave, Sheboygan, WI 53081 Phone: 920-459-4700 | |
Daniel R Farber, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2629 N 7th St, Sheboygan, WI 53083 Phone: 920-451-5000 | |
Dr. James S Hoell, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2629 N 7th St, Sheboygan, WI 53083 Phone: 920-451-5000 Fax: 920-451-5143 |